Video
Author(s):
In this video, Peter Lio, MD, FAAD, expands on his presentation at the 19th annual Winter Clinical Dermatology Conference by diving into molluscum contagiousum treatment and the potential of cantharidin 0.7% (VP-102; Verrica).
Peter Lio, MD, FAAD, clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois; founding director of the Chicago Integrative Eczema Center; and founding partner of Medical Dermatology Associates of Chicago, gave a presentation called, "What's Hot and New in Pediatric Dermatology," at the 19th annual Winter Clinical Dermatology Conference. In this video he goes into deep detail on current treatment, cantharidin 0.7% (VP-102; Verrica) potential FDA approval, and more.